Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 13 (2%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SUMATRIPTAN | 100MG | TABLET | Avoided shortage | 2020-12-09 | 2020-12-22 | 129864 |
| MYLAN-SUMATRIPTAN | 25MG | TABLET | Avoided shortage | 2020-12-09 | 2020-12-22 | 129867 |
| MYLAN-SUMATRIPTAN | 50MG | TABLET | Avoided shortage | 2020-12-09 | 2020-12-22 | 129870 |
| MYLAN-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-12-16 | 2021-01-12 | 130219 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130641 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130644 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-05 | 2021-03-17 | 130850 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2021-01-05 | 2021-02-03 | 130854 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| MYLAN-CINACALCET | 30MG | TABLET | Resolved | 2021-01-05 | 2021-01-13 | 130866 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2021-01-05 | 2021-07-21 | 130869 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| MYLAN-CILAZAPRIL | 5.0MG | TABLET | Resolved | 2021-01-05 | 2021-02-24 | 130875 |
| MYLAN-LAMOTRIGINE | 100MG | TABLET | Avoided shortage | 2021-01-05 | 2021-01-20 | 130878 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2021-01-05 | 2021-04-22 | 130881 |
| MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
| MYLAN-VERAPAMIL | 120MG | TABLET | Avoided shortage | 2021-01-14 | 2021-02-17 | 131547 |
| MYLAN-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-01-14 | 2021-04-13 | 131550 |
| MYLAN-SUMATRIPTAN | 25MG | TABLET | Resolved | 2021-01-14 | 2021-04-28 | 131553 |
| MYLAN-SUMATRIPTAN | 50MG | TABLET | Resolved | 2021-01-14 | 2021-04-19 | 131556 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |